Day: December 5, 2025

LIVERMORE, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) — FormFactor, Inc. (Nasdaq: FORM) today announced that it will be joining 14 other companies in collectively hosting the 14th Annual NYC Summit investor conference, being held Tuesday, December 16th at Mastro’s Steakhouse New York. The presentation material utilized during the NYC Summit will be made accessible on the events page of the Company’s website at www.formfactor.com. About the 14th Annual NYC SummitThe NYC Summit is collectively hosted and funded by participating companies and features a “round-robin” format consisting of small group meetings with company management teams. During the event, investors and analysts will have the opportunity to meet with the majority of the 15 management teams during the small group meeting sessions, as well as opportunities to meet with...

ROCKVILLE, Md. and SUZHOU, China, Dec. 04, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that it has received clearance from the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to conduct a global registrational Phase III study (POLARIS-1; NCT06051409) of its compound under investigation, olverembatinib, in combination with chemotherapy for the treatment of newly diagnosed patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). As the second global registrational Phase III study of olverembatinib that has been cleared...

Not for distribution to United States newswire services or for dissemination in the United States VANCOUVER, British Columbia, Dec. 04, 2025 (GLOBE NEWSWIRE) — Miata Metals Corp. (CSE:MMET) (FSE: 8NQ) (OTCQB: MMETF) (“Miata” or the “Company”) is pleased to announce that, further to its news release dated November 18, 2025, it has filed a final short form prospectus dated December 3, 2025 (the “Final Prospectus”) with the securities commissions in each of the provinces of Canada, except Quebec, in connection with its public offering of common shares of the Company (the “Common Shares”) at $0.48 per Common Share for aggregate gross proceeds of up to $10,000,080 (the “Offering”). The Offering is being conducted through a syndicate of agents led by Cormark Securities Inc. (collectively, the “Agents”). The Company has granted the Agents...